Skip to content

GEnetic Counseling Through Virtual Visits in Parkinson's Disease

GEnetic Counseling Through VIRTUAL Visits in Parkinson's Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04527146
Acronym
GET-VIRTUAL
Enrollment
370
Registered
2020-08-26
Start date
2021-01-01
Completion date
2023-11-01
Last updated
2025-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Brief summary

The research study is being conducted to compare methods of virtual genetic counseling for people with Parkinson's disease.

Detailed description

This research will evaluate different virtual methods of pre-test genetic counseling and post-test genetic results disclosure in people with Parkinson's disease. Participants will be randomized to receive different methods of genetic counseling using web-based, telephone, or telehealth methods. In both pre- and post-test counseling phases, remote genetic counseling methods will be compared to demonstrate equivalence. The primary outcomes will be equivalence on genetics knowledge and outcomes scales, and the revised impact of events scale. The purpose is to develop effective and scalable approaches to genetic counseling. This work is crucial for patient safety and will improve access to care through novel genetic counseling approaches.

Interventions

OTHERIMAGINE-PD

The Interactive, Multimedia Approach to Genetic Counseling to INform and Educate in Parkinson's Disease (IMAGINE-PD) is a novel, interactive, web-based, audiovisual, self-guided, genetic counseling tool in the development phase. Essential genetic counseling themes, outlined by a senior certified clinical genetics counselor in accordance with national guidelines, are presented in a web-based format, utilizing videos, text, pictures, and audio. Participants can interact with IMAGINE-PD at their own pace, with the ability to move backward and forward, repeat sections, and have the ability to submit questions to the genetic counselor via e-mail.

OTHERVirtual genetic counseling

The virtual visits will be conducted by a certified genetic counselor to provide all counseling in accordance with guidelines set forth by the National Society of Genetic Counselors. The counseling visit will be conducted in real-time on an established and secure audiovisual conferencing telemedicine platform (BlueJeans) within the Penn Chart/Epic electronic medical record dashboard.

The telephone counseling will be conducted by a certified genetic counselor to provide all counseling in accordance with guidelines set forth by the National Society of Genetic Counselors.

Sponsors

University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
OTHER
Masking
NONE

Intervention model description

Enrolled participants will be randomized into one of 4 groups based on pre- and post-genetic test counseling: (1)IMAGINE-PD/Virtual, (2)IMAGINE-PD/Telephone, (3)Virtual/Virtual, and (4)Virtual/Telephone.

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Provision of signed and dated informed consent form * Stated willingness to have clinical confirmation genetic testing, and comply with all study procedures and availability for the duration of the study * Male or female, over the age of 21. * English Speaking

Exclusion criteria

* Prior genetic counseling and/or clinical testing specifically for Parkinson's disease * Montreal Cognitive Assessment (MoCA) \< 21, or a prior diagnosis of dementia during the screening phase

Design outcomes

Primary

MeasureTime frameDescription
Genetics Knowledge4 weeks after pre-testing education/counselingGenetics Knowledge Scale (20-question true/false questionnaire, score range 0-20, higher scores mean greater knowledge)
Genetic Counseling Satisfaction (Post-Test)Immediately after disclosure counselingGenetic Counseling Satisfaction Scale (GCSS) (6-item scale, score range 6-30, higher scores mean greater satisfaction)
Test-Related Distress3 months after disclosure counselingRevised Impact of Events Scale (22-item, score range 0-88, higher scores mean greater event-related distress)

Secondary

MeasureTime frameDescription
State-Trait Anxiety Index -State Score6 months after disclosure counselingState-Trait Anxiety Index -State Score (STAI-S, 20-item, min score 20/max score 80, higher means greater anxiety). 20 items of the full STAI scale that includes 40 items are predefined according to the validated scale.
State-Trait Anxiety Index -Trait Score3 months after disclosure counselingState-Trait Anxiety Index -Trait Score (STAI-T, 20-item, min score 20/max score 80, higher means greater anxiety). 20 items of the full STAI scale that includes 40 items are predefined according to the validated scale.
Depression3 months after disclosure counselingGeriatric Depression Scale (GDS, 15-item score range 0-15, higher means greater depression)
Test-Related Distress6 months after disclosure counselingRevised Impact of Events Scale (22-item, score range 0-88, higher scores mean greater event-related distress)
Quality of Life in Parkinson's Disease3 months after disclosure counselingParkinsons disease quality of life scale- 39 (PDQ39). The PDQ-39 is a disease-specific health status measure that assess multiple dimensions of daily living. It is a validated, self-report measure for people with PD. Score range is from 0-100, with higher scores indicating a worse quality of life.
Genetic Counseling Satisfaction (Pre-Test)Immediately after pre-test education/counselingGenetic Counseling Satisfaction Scale (GCSS) (6-item scale, score range 6-30, higher scores mean greater satisfaction)
State-Trait Anxiety Index-State Score3 months after disclosure counselingState-Trait Anxiety Index -State Score (STAI-S, 20-item, min score 20/max score 80, higher means greater anxiety). 20 of the total 40 items included in the State Score are predefined according to the validated scale.

Countries

United States

Participant flow

Recruitment details

Eligible participants from UPenn's Parkinson's Disease and Movement Disorders Center's Molecular Integration in Neurological Diagnosis (MIND) Initiative who were 21 years old or older, willing to complete confirmatory genetic testing, willing to learn their genetic test results, and had access to a telephone, computer, and videoconferencing device. Key exclusion criteria were prior genetic counseling for PD, prior diagnosis of dementia, or scored \<21 on the Montreal Cognitive Assessment (MoCA).

Pre-assignment details

A factorial design schema was used for group randomization based on pre-test education or counseling (i.e., IMAGINE-PD or Virtual) and post-test counseling (i.e. Telephone or Virtual) modalities. All randomized participants were included in an intention-to-treat (ITT) analysis. A per protocol (PP) analysis defined a subset of participants with data for all 3 primary outcome variables (i.e., completed visit 3 for genetic counseling satisfaction, genetics knowledge, and test-related distress).

Participants by arm

ArmCount
IMAGINE-PD/Virtual
Pre-test genetic counseling through the Interactive Multimedia Approach to Genetic counseling to INform and Educate in Parkinson's Disease (IMAGINE-PD) website. Genetic results disclosure via virtual visit with a genetic counselor. IMAGINE-PD: The Interactive, Multimedia Approach to Genetic Counseling to INform and Educate in Parkinson's Disease (IMAGINE-PD) is a novel, interactive, web-based, audiovisual, self-guided, genetic counseling tool in the development phase. Essential genetic counseling themes, outlined by a senior certified clinical genetics counselor in accordance with national guidelines, are presented in a web-based format, utilizing videos, text, pictures, and audio. Participants can interact with IMAGINE-PD at their own pace, with the ability to move backward and forward, repeat sections, and have the ability to submit questions to the genetic counselor via e-mail. Virtual genetic counseling: The virtual visits will be conducted by a certified genetic counselor to provide all counseling in accordance with guidelines set forth by the National Society of Genetic Counselors. The counseling visit will be conducted in real-time on an established and secure audiovisual conferencing telemedicine platform (BlueJeans or Zoom).
94
IMAGINE-PD/Telephone
Pre-test genetic counseling through the Interactive Multimedia Approach to Genetic counseling to INform and Educate in Parkinson's Disease (IMAGINE-PD) website. Genetic results disclosure via telephone with a genetic counselor. IMAGINE-PD: The Interactive, Multimedia Approach to Genetic Counseling to INform and Educate in Parkinson's Disease (IMAGINE-PD) is a novel, interactive, web-based, audiovisual, self-guided, genetic counseling tool in the development phase. Essential genetic counseling themes, outlined by a senior certified clinical genetics counselor in accordance with national guidelines, are presented in a web-based format, utilizing videos, text, pictures, and audio. Participants can interact with IMAGINE-PD at their own pace, with the ability to move backward and forward, repeat sections, and have the ability to submit questions to the genetic counselor via e-mail. Telephone genetic counseling: The telephone counseling will be conducted by a certified genetic counselor to provide all counseling in accordance with guidelines set forth by the National Society of Genetic Counselors.
91
Virtual/Telephone
Pre-test genetic counseling virtual visit with a genetic counselor. Genetic results disclosure via telephone with a genetic counselor. Virtual genetic counseling: The virtual visits will be conducted by a certified genetic counselor to provide all counseling in accordance with guidelines set forth by the National Society of Genetic Counselors. The counseling visit will be conducted in real-time on an established and secure audiovisual conferencing telemedicine platform (BlueJeans or Zoom). Telephone genetic counseling: The telephone counseling will be conducted by a certified genetic counselor to provide all counseling in accordance with guidelines set forth by the National Society of Genetic Counselors.
92
Virtual/Virtual
Pre-test genetic counseling and genetic results disclosure via virtual visit with a genetic counselor. Virtual genetic counseling: The virtual visits will be conducted by a certified genetic counselor to provide all counseling in accordance with guidelines set forth by the National Society of Genetic Counselors. The counseling visit will be conducted in real-time on an established and secure audiovisual conferencing telemedicine platform (BlueJeans or Zoom).
93
Total370

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003
Overall StudyAdverse Event0010
Overall StudyDeath0110
Overall StudyIneligible after randomization2022
Overall StudyLost to Follow-up1391613
Overall StudyMoved to a different group6302
Overall StudyWithdrawal by Subject1215716

Baseline characteristics

CharacteristicTotalVirtual/VirtualIMAGINE-PD/VirtualVirtual/TelephoneIMAGINE-PD/Telephone
Age, Continuous69 years70 years70 years68 years68 years
Baseline Genetics Knowledge (GKS) total17 units on a scale16 units on a scale16 units on a scale17 units on a scale17 units on a scale
Baseline Geriatric Depression Scale (GDS) total3 units on a scale3 units on a scale3 units on a scale2 units on a scale2 units on a scale
Baseline Montreal Cognitive Assessment (MoCA) total27 units on a scale26 units on a scale27 units on a scale27 units on a scale27 units on a scale
Baseline Parkinsons Disease Questionnaire-39 (PDQ-39) item summary index (PDQ-39)19 units on a scale19 units on a scale20 units on a scale18 units on a scale18 units on a scale
Baseline State-Trait Anxiety Scale (STAI)-state36 units on a scale36 units on a scale36 units on a scale36 units on a scale37 units on a scale
Baseline State Trait Anxiety Scale (STAI)-trait34 units on a scale35 units on a scale35 units on a scale34 units on a scale34 units on a scale
Disease Duration7 years7 years6 years7 years6 years
Education
Associate
58 Participants15 Participants12 Participants17 Participants14 Participants
Education
Bachelor
126 Participants28 Participants34 Participants30 Participants34 Participants
Education
Graduate
156 Participants39 Participants44 Participants39 Participants34 Participants
Education
HS
18 Participants5 Participants2 Participants4 Participants7 Participants
Education
< HS
3 Participants2 Participants1 Participants0 Participants0 Participants
Education
Missing
9 Participants4 Participants1 Participants2 Participants2 Participants
Genetic Screening Result
Negative
303 Participants82 Participants80 Participants71 Participants70 Participants
Genetic Screening Result
Positive
67 Participants11 Participants14 Participants21 Participants21 Participants
PD family history
No/Unk/Missing
220 Participants56 Participants61 Participants54 Participants49 Participants
PD family history
Yes
150 Participants37 Participants33 Participants38 Participants42 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
7 Participants3 Participants2 Participants2 Participants0 Participants
Race (NIH/OMB)
Black or African American
6 Participants1 Participants3 Participants0 Participants2 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
8 Participants4 Participants1 Participants2 Participants1 Participants
Race (NIH/OMB)
White
349 Participants85 Participants88 Participants88 Participants88 Participants
Region of Enrollment
United States
370 participants93 participants94 participants92 participants91 participants
Sex: Female, Male
Female
131 Participants26 Participants44 Participants29 Participants32 Participants
Sex: Female, Male
Male
239 Participants67 Participants50 Participants63 Participants59 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 941 / 911 / 920 / 93
other
Total, other adverse events
83 / 9482 / 9178 / 9283 / 93
serious
Total, serious adverse events
0 / 940 / 910 / 920 / 93

Outcome results

Primary

Genetic Counseling Satisfaction (Post-Test)

Genetic Counseling Satisfaction Scale (GCSS) (6-item scale, score range 6-30, higher scores mean greater satisfaction)

Time frame: Immediately after disclosure counseling

ArmMeasureValue (MEDIAN)
IMAGINE-PD/VirtualGenetic Counseling Satisfaction (Post-Test)24 score on a scale
IMAGINE-PD/TelephoneGenetic Counseling Satisfaction (Post-Test)25 score on a scale
Virtual/TelephoneGenetic Counseling Satisfaction (Post-Test)25 score on a scale
Virtual/VirtualGenetic Counseling Satisfaction (Post-Test)26 score on a scale
Primary

Genetics Knowledge

Genetics Knowledge Scale (20-question true/false questionnaire, score range 0-20, higher scores mean greater knowledge)

Time frame: 4 weeks after pre-testing education/counseling

ArmMeasureValue (MEDIAN)
IMAGINE-PD/VirtualGenetics Knowledge16 score on a scale
IMAGINE-PD/TelephoneGenetics Knowledge17 score on a scale
Virtual/TelephoneGenetics Knowledge17 score on a scale
Virtual/VirtualGenetics Knowledge16 score on a scale
Primary

Test-Related Distress

Revised Impact of Events Scale (22-item, score range 0-88, higher scores mean greater event-related distress)

Time frame: 3 months after disclosure counseling

ArmMeasureValue (MEDIAN)
IMAGINE-PD/VirtualTest-Related Distress0 score on a scale
IMAGINE-PD/TelephoneTest-Related Distress1 score on a scale
Virtual/TelephoneTest-Related Distress0 score on a scale
Virtual/VirtualTest-Related Distress0 score on a scale
Secondary

Depression

Geriatric Depression Scale (GDS, 15-item score range 0-15, higher means greater depression)

Time frame: 3 months after disclosure counseling

ArmMeasureValue (MEDIAN)
IMAGINE-PD/VirtualDepression3 score on a scale
IMAGINE-PD/TelephoneDepression3 score on a scale
Virtual/TelephoneDepression2.5 score on a scale
Virtual/VirtualDepression3 score on a scale
Secondary

Depression

Geriatric Depression Scale (GDS, 15-item score range 0-15, higher means greater depression)

Time frame: 6 months after disclosure counseling

ArmMeasureValue (MEDIAN)
IMAGINE-PD/VirtualDepression3 score on a scale
IMAGINE-PD/TelephoneDepression3 score on a scale
Virtual/TelephoneDepression3 score on a scale
Virtual/VirtualDepression3 score on a scale
Secondary

Genetic Counseling Satisfaction (Pre-Test)

Genetic Counseling Satisfaction Scale (GCSS) (6-item scale, score range 6-30, higher scores mean greater satisfaction)

Time frame: Immediately after pre-test education/counseling

ArmMeasureValue (MEDIAN)
IMAGINE-PD/VirtualGenetic Counseling Satisfaction (Pre-Test)22 score on a scale
IMAGINE-PD/TelephoneGenetic Counseling Satisfaction (Pre-Test)23 score on a scale
Virtual/TelephoneGenetic Counseling Satisfaction (Pre-Test)24 score on a scale
Virtual/VirtualGenetic Counseling Satisfaction (Pre-Test)25 score on a scale
Secondary

Quality of Life in Parkinson's Disease

Parkinsons disease quality of life scale- 39 (PDQ39). The PDQ-39 is a disease-specific health status measure that assess multiple dimensions of daily living. It is a validated, self-report measure for people with PD. Score range is from 0-100, with higher scores indicating a worse quality of life.

Time frame: 6 months after disclosure counseling

ArmMeasureValue (MEDIAN)
IMAGINE-PD/VirtualQuality of Life in Parkinson's Disease20.99 score on a scale
IMAGINE-PD/TelephoneQuality of Life in Parkinson's Disease15.31 score on a scale
Virtual/TelephoneQuality of Life in Parkinson's Disease17.79 score on a scale
Virtual/VirtualQuality of Life in Parkinson's Disease19.22 score on a scale
Secondary

Quality of Life in Parkinson's Disease

Parkinsons disease quality of life scale- 39 (PDQ39). The PDQ-39 is a disease-specific health status measure that assess multiple dimensions of daily living. It is a validated, self-report measure for people with PD. Score range is from 0-100, with higher scores indicating a worse quality of life.

Time frame: 3 months after disclosure counseling

ArmMeasureValue (MEDIAN)
IMAGINE-PD/VirtualQuality of Life in Parkinson's Disease21.41 score on a scale
IMAGINE-PD/TelephoneQuality of Life in Parkinson's Disease15.83 score on a scale
Virtual/TelephoneQuality of Life in Parkinson's Disease16.56 score on a scale
Virtual/VirtualQuality of Life in Parkinson's Disease18.44 score on a scale
Secondary

State-Trait Anxiety Index -State Score

State-Trait Anxiety Index -State Score (STAI-S, 20-item, min score 20/max score 80, higher means greater anxiety). 20 items of the full STAI scale that includes 40 items are predefined according to the validated scale.

Time frame: 6 months after disclosure counseling

ArmMeasureValue (MEDIAN)
IMAGINE-PD/VirtualState-Trait Anxiety Index -State Score35 score on a scale
IMAGINE-PD/TelephoneState-Trait Anxiety Index -State Score36 score on a scale
Virtual/TelephoneState-Trait Anxiety Index -State Score34.5 score on a scale
Virtual/VirtualState-Trait Anxiety Index -State Score36 score on a scale
Secondary

State-Trait Anxiety Index-State Score

State-Trait Anxiety Index -State Score (STAI-S, 20-item, min score 20/max score 80, higher means greater anxiety). 20 of the total 40 items included in the State Score are predefined according to the validated scale.

Time frame: 3 months after disclosure counseling

ArmMeasureValue (MEDIAN)
IMAGINE-PD/VirtualState-Trait Anxiety Index-State Score35 score on a scale
IMAGINE-PD/TelephoneState-Trait Anxiety Index-State Score36 score on a scale
Virtual/TelephoneState-Trait Anxiety Index-State Score35 score on a scale
Virtual/VirtualState-Trait Anxiety Index-State Score36 score on a scale
Secondary

State-Trait Anxiety Index -Trait Score

State-Trait Anxiety Index -Trait Score (STAI-T, 20-item, min score 20/max score 80, higher means greater anxiety). 20 items of the full STAI scale that includes 40 items are predefined according to the validated scale.

Time frame: 6 months after disclosure counseling

ArmMeasureValue (MEDIAN)
IMAGINE-PD/VirtualState-Trait Anxiety Index -Trait Score34 score on a scale
IMAGINE-PD/TelephoneState-Trait Anxiety Index -Trait Score34 score on a scale
Virtual/TelephoneState-Trait Anxiety Index -Trait Score35 score on a scale
Virtual/VirtualState-Trait Anxiety Index -Trait Score35 score on a scale
Secondary

State-Trait Anxiety Index -Trait Score

State-Trait Anxiety Index -Trait Score (STAI-T, 20-item, min score 20/max score 80, higher means greater anxiety). 20 items of the full STAI scale that includes 40 items are predefined according to the validated scale.

Time frame: 3 months after disclosure counseling

ArmMeasureValue (MEDIAN)
IMAGINE-PD/VirtualState-Trait Anxiety Index -Trait Score34 score on a scale
IMAGINE-PD/TelephoneState-Trait Anxiety Index -Trait Score33 score on a scale
Virtual/TelephoneState-Trait Anxiety Index -Trait Score38 score on a scale
Virtual/VirtualState-Trait Anxiety Index -Trait Score34 score on a scale
Secondary

Test-Related Distress

Revised Impact of Events Scale (22-item, score range 0-88, higher scores mean greater event-related distress)

Time frame: 6 months after disclosure counseling

ArmMeasureValue (MEDIAN)
IMAGINE-PD/VirtualTest-Related Distress0 score on a scale
IMAGINE-PD/TelephoneTest-Related Distress0 score on a scale
Virtual/TelephoneTest-Related Distress0 score on a scale
Virtual/VirtualTest-Related Distress0 score on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026